Search Results

Seasonal and perennial allergic conjunctivitis: the possible role of nasal allergy

Author: Pelikan, Zdenek

Source: Clinical & Experimental Ophthalmology, Volume 37, Number 5, July 2009 , pp. 448-457(10)

Publisher: Blackwell Publishing

Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms

Authors: Torkildsen, G. L.; Gomes, P.; Welch, D.; Gopalan, G.; Srinivasan, S.

Source: Clinical & Experimental Allergy, Volume 39, Number 7, July 2009 , pp. 1052-1059(8)

Publisher: Blackwell Publishing

Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis?

Authors: Naclerio, Robert M.; Philpot, Edward E.; Rosenwasser, Lanny J.; Mahr, Todd; Gomes, Paul J.; Abelson, Mark B.

Source: Allergy and Asthma Proceedings, Volume 30, Number 2, March/April 2009 , pp. 212-214(3)

Publisher: OceanSide Publications, Inc

A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis

Authors: Rosenwasser, Lanny J.; Mahr, Todd; Abelson, Mark B.; Gomes, Paul J.; Kennedy, Kathryn

Source: Allergy and Asthma Proceedings, Volume 29, Number 6, November-December 2008 , pp. 644-653(10)

Publisher: OceanSide Publications, Inc

Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge

Authors: Abelson, Mark; Spangler, Dennis; Epstein, Arthur; Mah, Francis; Crampton, H. Jerome

Source: Current Eye Research, Volume 32, Number 12, December 2007 , pp. 1017-1022(6)

Publisher: Informa Healthcare

Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo

Authors: Galatowicz, Grazyna; Ajayi, Yetunde; Stern, Michael E.; Calder, Virginia L.

Source: Clinical & Experimental Allergy, Volume 37, Number 11, November 2007 , pp. 1648-1656(9)

Publisher: Blackwell Publishing

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis

Authors: Abelson, Mark B.; Gomes, Paul J.; Pasquine, Terri; Edwards, Michael R.; Gross, Robert D.; Robertson, Stella M.

Source: Allergy and Asthma Proceedings, Volume 28, Number 4, July-August 2007 , pp. 427-433(7)

Publisher: OceanSide Publications, Inc

Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge

Authors: Mah, Francis S.; Rosenwasser, Lanny J.; Townsend, William D.; Greiner, Jack V.; Bensch, George

Source: Current Medical Research and Opinion, Volume 23, Number 6, June 2007 , pp. 1445-1452(8)

Publisher: Informa Healthcare

Pharmacology, clinical efficacy and safety of olopatadine hydrochloride

Authors: Lichtenstein, Steven J; Abelson, Mark B

Source: Expert Review of Clinical Immunology, Volume 2, Number 3, May 2006 , pp. 341-351(11)

Publisher: Expert Reviews

Myeloperoxidase Release After Allergen-Specific Conjunctival Challenge

Authors: Monteseirín, J.; Fernández‐Pineda, I.; Chacón, P.; Vega, A.; Bonilla, I.; Camacho, M.; Fernández‐Delgado, L.; Conde, J.; Sobrino, F.

Source: Journal of Asthma, Volume 41, Number 6, 2004 , pp. 639-643(5)

Publisher: Informa Healthcare

Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model

Authors: Abelson, Mark B.; Greiner, Jack V.

Source: Current Medical Research and Opinion, Volume 20, Number 12, December 2004 , pp. 1953-1958(6)

Publisher: Informa Healthcare

Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population

Authors: Mark B. Abelson; Nancy J. Ferzola; Cecilia L. McWhirter; Henry J. Crampton

Source: Pediatric Allergy and Immunology, Volume 15, Number 6, December 2004 , pp. 551-557(7)

Publisher: Blackwell Publishing

A review of olopatadine for the treatment of ocular allergy

Author: Mark B Abelson

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 9, 1 September 2004 , pp. 1979-1994(16)

Publisher: Informa Healthcare

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model

Authors: Lanier, Bobby Q.; Finegold, Ira; D'Arienzo, Peter; Granet, David; Epstein, Arthur B.; Ledgerwood, Greg L.

Source: Current Medical Research and Opinion, Volume 20, Number 8, 1 August 2004 , pp. 1227-1233(7)

Publisher: Informa Healthcare

Preclinical and Clinical Antiallergic Effect of Olopatadine 0.2% Solution 24 Hours after Topical Ocular Administration

Authors: Vogelson, Cullen T.; Abelson, Mark B.; Pasquine, Terri; Stephens, Donna M.; Gamache, Daniel A.; Gross, Robert D.; Robertson, Stella M.; Yanni, John M.

Source: Allergy and Asthma Proceedings, Volume 25, Number 1, January-February 2004 , pp. 69-75(7)

Publisher: OceanSide Publications, Inc

Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions

Authors: Ciprandi, Giorgio; Cosentino, Cristina; Milanese, Manlio; Tosca, Maria A.

Source: Annals of Allergy, Asthma and Immunology, Volume 90, Number 4, April 2003 , pp. 434-438(5)

Publisher: American College of Allergy, Asthma, & Immunology

IgE-mediated allergy to fungal allergens in Finland with special reference toAlternaria alternata and Cladosporium herbarum

Authors: Reijula, Kari; Leino, Marina; Mussalo-Rauhamaa, Helena; Nikulin, Marjo; Alenius, Harri; Mikkola, Jari; Elg, Peter; Kari, Osmo; Mäkinen-Kiljunen, Soili; Haahtela, Tari

Source: Annals of Allergy, Asthma and Immunology, Volume 91, Number 3, September 2003 , pp. 280-287(8)

Publisher: American College of Allergy, Asthma, & Immunology

Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans

Authors: Leonardi A.; Abelson M.B.

Source: Clinical Therapeutics, Volume 25, Number 10, October 2003 , pp. 2539-2552(14)

Publisher: Elsevier

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models

Authors: Spangler D.L.; Abelson M.B.; Ober A.; Gotnes P.J.

Source: Clinical Therapeutics, Volume 25, Number 8, August 2003 , pp. 2245-2267(23)

Publisher: Elsevier

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial

Author: Crampton H.J.

Source: Clinical Therapeutics, Volume 25, Number 7, July 2003 , pp. 1975-1987(13)

Publisher: Elsevier